Vital Therapies Announces Upcoming Fourth Quarter and Full Year 2016 Financial Results Conference Call With Webcast
February 27, 2017 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Feb. 27, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Provides Corporate Update
January 09, 2017 08:00 ET
|
Vital Therapies, Inc.
SAN DIEGO, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Announces Third Quarter Financial Results
November 03, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
October 25, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Provides Corporate Update
September 13, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Announces Appointment of Former Receptos President and CEO Faheem Hasnain to Its Board of Directors
August 15, 2016 08:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Announces Second Quarter Financial Results
August 02, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast
July 21, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, July 21, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Enrolls First Subject in VTL-308
May 23, 2016 08:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, May 23, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Vital Therapies Announces First Quarter Financial Results
May 09, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, May 09, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...